Pet oncology specialist Torigen highlights data accumulation as key driver for growth

摘要

Established in 2013, Torigen Pharmaceuticals rose to prominence last year when it won the Kansas City Animal Health Investment Forum. Animal Pharm analyst Daniel Willis spoke to Torigen founder and chief executive Ashley Kalinauskas to see what the company has been up to since its triumph and find out about its future plans.Dr Lucroy most recently worked for US veterinary care firm MedVet as clinical studies center director and medical oncologist for three years. He has also served as a research advisor of technology acquisitions for Elanco, a role he spent four years in from 2011 to 2016, as well as a medical oncologist for VCA Veterinary Specialty Center from 2007 to 2011. He started his career as an associate professor and chief of clinical oncology for Purdue University from 2003 to 2007.